+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kallikrein Inhibitor"

Kallikrein Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Kallikrein Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Global Hereditary Angioedema Therapeutics Market by Drug Class (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor, Kallikrein Inhibitor), Treatment Type (On-Demand, Prophylaxis), Route Of Administration - Forecast 2024-2030 - Product Thumbnail Image

Global Hereditary Angioedema Therapeutics Market by Drug Class (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor, Kallikrein Inhibitor), Treatment Type (On-Demand, Prophylaxis), Route Of Administration - Forecast 2024-2030

  • Report
  • March 2024
  • 190 Pages
  • Global
From
Global Angioedema Treatment Market by Drugs Type (C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), Route of Administration (Injections, Oral), End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Angioedema Treatment Market by Drugs Type (C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), Route of Administration (Injections, Oral), End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 100 Pages
  • Global
From
Hereditary Angioedema Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 196 Pages
  • Global
From
Hereditary Angioedema - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Hereditary Angioedema Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Hereditary Angioedema Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 180 Pages
  • Global
From
Global Hereditary Angioedema Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Hereditary Angioedema Therapeutics Market 2023-2027

  • Report
  • July 2023
  • 156 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027) - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • Report
  • August 2022
  • 110 Pages
  • Global
From
Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F

  • Report
  • April 2024
  • 82 Pages
From
Hereditary Angioedema Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Hereditary Angioedema Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Market Spotlight: Hereditary Angioedema - Product Thumbnail Image

Market Spotlight: Hereditary Angioedema

  • Report
  • March 2021
  • 43 Pages
  • Global
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 208 Pages
  • United States
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Kallikrein Inhibitor market is a subset of the Immune Disorders Drugs market. Kallikrein Inhibitors are a type of drug used to treat a variety of immune disorders, including allergies, asthma, and autoimmune diseases. These drugs work by blocking the activity of kallikrein, an enzyme that plays a role in inflammation. Kallikrein Inhibitors are typically administered orally or intravenously, and can be used in combination with other drugs to treat more severe cases. Kallikrein Inhibitors are becoming increasingly popular due to their effectiveness in treating a wide range of immune disorders. They are also relatively safe, with few side effects. As a result, the Kallikrein Inhibitor market is expected to continue to grow in the coming years. Some companies in the Kallikrein Inhibitor market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more